- Home
- GDYN vs GLPG Comparison
GDYN vs GLPG Comparison
Compare GDYN & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- GLPG
- Stock Information
- Founded
- GDYN 2006
- GLPG 1999
- Country
- GDYN United States
- GLPG Belgium
- Employees
- GDYN N/A
- GLPG N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- GDYN Technology
- GLPG Health Care
- Exchange
- GDYN Nasdaq
- GLPG Nasdaq
- Market Cap
- GDYN 1.6B
- GLPG 1.8B
- IPO Year
- GDYN N/A
- GLPG 2005
- Fundamental
- Price
- GDYN $16.36
- GLPG $25.99
- Analyst Decision
- GDYN Strong Buy
- GLPG Sell
- Analyst Count
- GDYN 6
- GLPG 5
- Target Price
- GDYN $19.17
- GLPG $26.75
- AVG Volume (30 Days)
- GDYN 884.2K
- GLPG 279.3K
- Earning Date
- GDYN 05-01-2025
- GLPG 05-02-2025
- Dividend Yield
- GDYN N/A
- GLPG N/A
- EPS Growth
- GDYN N/A
- GLPG N/A
- EPS
- GDYN 0.05
- GLPG 1.16
- Revenue
- GDYN $350,571,000.00
- GLPG $285,380,474.00
- Revenue This Year
- GDYN $24.35
- GLPG $0.08
- Revenue Next Year
- GDYN $17.42
- GLPG $0.23
- P/E Ratio
- GDYN $327.50
- GLPG $22.20
- Revenue Growth
- GDYN 12.04
- GLPG 14.99
- 52 Week Low
- GDYN $9.07
- GLPG $22.36
- 52 Week High
- GDYN $25.50
- GLPG $34.65
- Technical
- Relative Strength Index (RSI)
- GDYN 29.17
- GLPG 52.81
- Support Level
- GDYN $16.57
- GLPG $25.44
- Resistance Level
- GDYN $17.91
- GLPG $27.01
- Average True Range (ATR)
- GDYN 1.07
- GLPG 0.55
- MACD
- GDYN -0.34
- GLPG -0.05
- Stochastic Oscillator
- GDYN 3.95
- GLPG 34.16
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.